Darren R. Feldman

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study

  EClinicalMedicine · 2026-03-31 · 3 citations

• A multi-institution analysis of outcomes with first-line ipilimumab and nivolumab for 514 patients with metastatic clear cell renal cell carcinoma by number of doses.

  Journal of Clinical Oncology · 2026-03-01

• Sarcomatoid versus rhabdoid dedifferentiation and histologic grade-specific outcomes in metastatic clear cell renal cell carcinoma (mccRCC): A multi-institutional analysis of 514 patients.

  Journal of Clinical Oncology · 2026-03-01

• A phase 1/2 study to assess peptidomimetic carbonic anhydrase IX imaging and therapy with [ ⁶⁸ Ga]Ga-DPI-4452 and [ ¹⁷⁷ Lu]Lu-DPI-4452 in patients with advanced clear cell renal cell carcinoma and other solid tumors.

  Journal of Clinical Oncology · 2026-03-01

• Clinical outcomes and tolerability of ipilimumab/nivolumab in older (≥70 years) versus younger patients with metastatic clear cell RCC: A multi-institutional analysis of 514 patients.

  Journal of Clinical Oncology · 2026-03-01

• Cardiovascular disease risk among long-term testicular cancer survivors following contemporary cisplatin-based chemotherapy

  JNCI Journal of the National Cancer Institute · 2026-02-06

• Can Novel Biomarkers Augment Traditional Surveillance Paradigms in Early-stage Testicular Germ Cell Tumors? A Case Study in Pre-clinical Relapse Detection Using a Combination Micro-RNA-371a-3p and 372-3p Assay

  Urology · 2025-12-05

• Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

  2025-11-25

• Supplementary Table S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

  2025-11-25

• Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

  2025-11-25

• Validation of the Testicular Health Outcomes Report ( <scp>THOR</scp> ): a testicular cancer health‐related quality of life instrument

  British Journal of Urology · 2025-11-04

• Abstract B098: Global-scale patient-partnered genomic databanking: unlocking therapeutic and biological insights in rare cancers through decentralized recruitment and open data sharing

  Cancer Epidemiology Biomarkers & Prevention · 2025-09-18

• Impact of Population Pharmacogenomics on Cisplatin‐Induced Neurotoxicities in Testicular Cancer Survivors

  Cancer Medicine · 2025-09-01 · 1 citations

• Optimizing the Approach to Surgical Decision-Making in Patients With Pure Seminoma Metastatic to the Retroperitoneum

  The Journal of Urology · 2025-07-25

• Baseline health‐related quality‐of‐life metrics among patients with testicular germ cell tumours

  British Journal of Urology · 2025-07-10 · 2 citations

• Performance Characteristics of an Analytic Model Predicting Retroperitoneal Lymph Node Dissection Pathology Following First-Line Chemotherapy for Patients With Metastatic Nonseminomatous Germ Cell Tumors

  The Journal of Urology · 2025-07-07

• Optimal Management of Stage II Seminoma: Preventing Harm While Preserving Cure

  JCO Oncology Practice · 2025-06-13 · 2 citations

• Post-Transplant Pain and Paralysis: Neurologic Amyotrophy as an Atypical Cause of Shoulder Dysfunction Following Hematopoietic Stem Cell Transplant

  Cancers · 2025-05-29 · 1 citations

• STARLITE 2: Phase 2 study of nivolumab plus ¹⁷⁷ lutetium-labeled anti–carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ( ¹⁷⁷ Lu-girentuximab) in patients with advanced clear cell renal cell carcinoma (ccRCC).

  Journal of Clinical Oncology · 2025-05-28 · 2 citations

• KEAP1 mutated renal cell carcinoma (RCC): Characterization of an emerging molecularly defined RCC subtype.

  Journal of Clinical Oncology · 2025-05-28